RT info:eu-repo/semantics/article
T1 Metabolic syndrome after Roux-en-Y gastric bypass in patients with morbid obesity: Five years of follow-up, a before and after study.
A1 Rodríguez Álvarez, Cristobalina
A1 Acosta Torrecilla, Alfonso Orelve
A1 Arias, Ángeles
A1 González Dávila, Enrique Francisco
K1 Laparoscopic gastric bypass
K1 Bariatric surgery
K1 Metabolic syndrome
K1 Morbid obesity
K1 Before-after study
AB Background: Metabolic syndrome (MetS) is common among morbidly obese patients undergoing bariatric surgery. The aim of this study is to analyse prevalence and evolution of MetS in patients suffering from morbidobesity, before and after bariatric surgery, during a follow-up period of 5 years.Methods: A before-after study was carried out including 156 patients with MetS. The definition of metabolicsyndrome according to the Joint Interim Statement (JIS) definition was used. Demographic, as well as anthropometric, biochemical, and clinical analyses were assessed before, as well as 2 and 5 years after performinglaparoscopic Roux-en-Y gastric bypass (RYGB).Results: High BMI (100%), elevated blood pressure (78%) and low levels of high density lipoprotein (70%) werethe most prevalent criteria for MetS. The percentage of people with MetS decreased significantly to 48.9% at 2years and 24.1% at 5 years. The weight was also significantly reduced at 2 years, although at 5 years a reboundeffect is already observed. Percentage of total weight loss (%TWL) and excess BMI loss (%EBMIL) were.49.7 ± 19.4% and 68.2 ± 18.9%, respectively, at 2 years and 29.3 ± 11.6% and 62.0 ± 24.9 at 5 years,both presenting significant differences (p < 0.001).Conclusion: RYGB in obese patients is associated with a significant improvement of MetS and its comorbidities.Insufficient weight loss is the main factor related to the prevalence of MetS.
SN 1743-9159
YR 2020
FD 2020
LK http://riull.ull.es/xmlui/handle/915/34824
UL http://riull.ull.es/xmlui/handle/915/34824
LA en
DS Repositorio institucional de la Universidad de La Laguna
RD 09-may-2024